Skip to main content
Clinical Trials/NCT00160290
NCT00160290TerminatedPhase 4

An Open, Randomized, Parallel Group, Single Center Study to Investigate the Effect of Lactulose Versus Plantago Ovate on the Quality of Life of Patients With Hard Stools and Hemorrhoids or Anal Fissure

Solvay Pharmaceuticals8 sites in 1 country97 target enrollmentStarted: March 2002Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Terminated
Enrollment
97
Locations
8
Primary Endpoint
Quality of life of patients with hard stools and hemorrhoids or anal fissure

Study Overview

Brief Summary

To demonstrate that lactulose acts as a stool softener, relieving the pain at defecation, improving the number of defecations and regulating the colonic transit time in patients suffering of hemorrhoids or anal fissure. To compare efficacy and quality of life in patients treated either with lactulose or plantago ovate.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients suffering from symptomatic hemorrhoids, or symptomatic anal fissure.

Exclusion Criteria

  • Patients suffering from malignant tumor in the intestine or the anal-rectal region, irritable colon, intestine inflammatory disease.

Arms & Interventions

B

Active Comparator

Plantago Group

Intervention: Plantago ovata (Drug)

A

Experimental

Lactulose Group

Intervention: Lactulose (Drug)

Outcomes

Primary Outcomes

Quality of life of patients with hard stools and hemorrhoids or anal fissure

Time Frame: 6 weeks

Secondary Outcomes

  • Gastrointestinal Symptoms Rating Scale(6 weeks)
  • Bristol stool consistency scale(6 weeks)
  • Number of episodes of rectal bleeding(6 weeks)
  • Need of rescue medication(6 weeks)

Investigators

Sponsor Class
Industry

Study Sites (8)

Loading locations...

Similar Trials

Trial to Evaluate Effect of Lactulose on... | Clinical Trial